Laboratorios COFASA

What Laboratorios COFASA does

Laboratorios COFASA, legally Compañía Farmacéutica S.A. de C.V., is a Salvadoran pharmaceutical manufacturer founded in 1966 and headquartered in Santa Tecla, San Salvador. The company develops, manufactures, and distributes over-the-counter (OTC) and prescription (OTX) pharmaceutical products across more than 30 branded SKUs spanning analgesics, anti-infectives, cardiovascular, CNS, respiratory, gastrointestinal, dermatological, and nutritional supplement categories. Its manufacturing operations cover liquids, semi-solids, solids, and powders, certified under ISO 9001:2015 since 2008 and WHO GMP (BPM) since 2016, with capacity including 1,500-2,000L tanks, 2,000-2,500 bottles/hour filling, 3,600 ampoules/hour ampoule filling, and 50,000-300,000 tablets/hour compression. The company also offers contract manufacturing (maquila) services to third-party pharmaceutical laboratories and private-label brands, leveraging its certified quality infrastructure for additional revenue.

The company's go-to-market relies on a hybrid model: a direct medical-representative sales team engages healthcare professionals and institutional buyers in El Salvador, while regional distributor partners reach consumers in Guatemala, Honduras, Panama, and Dominican Republic through pharmacy chains and retail outlets. Its customer base spans three primary segments — general consumers purchasing OTC self-medication products, healthcare professionals prescribing OTX medications, and third-party laboratories contracting maquila services. Pricing is not publicly disclosed and is administered through pharmacy channels and distributor relationships. Brand visibility is reinforced through CSR initiatives including the 'COFASA Te Cuida' community health campaign, 'Aprendiendo Juntos' school health education, and a recently announced partnership with Fundación INQUIFAR to support pharmaceutical sciences education in El Salvador.

Name

Laboratorios COFASA

Legal name

Compañía Farmaceutica S.A de C.V

Website

https://labcofasa.com

Company type

Private

Founded year

1966

Operating status

Operating

Headcount range

11–50 employees

Short description

Laboratorios COFASA is a 58-year-old Salvadoran pharmaceutical manufacturer that produces and distributes OTC and prescription pharmaceutical products across Central America and the Caribbean, and offers contract manufacturing services to third-party laboratories.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH)

Keywords

• Pharmaceutical manufacturing
• OTC medications
• Prescription drugs
• Contract manufacturing
• Nutritional supplements

Headquarters

HQ city

San Salvador

HQ country

El Salvador

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales (OTC and OTX): Laboratorios COFASA generates revenue primarily through the manufacture and sale of over-the-counter (OTC) and prescription (OTX) pharmaceutical products including analgesics, nutritional supplements, dermatologicals, cardiovascular drugs, and anti-infectives across Central American and Caribbean markets.
2. Contract Manufacturing (Maquila): COFASA offers maquila (contract manufacturing) services to other pharmaceutical laboratories and private-label brands in liquid, semi-solid, and solid production areas, including fabrication, filling, and packaging services.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Laboratorios COFASA is a pharmaceutical laboratory that manufactures and distributes over-the-counter (OTC) and prescription (OTX) pharmaceutical products, as well as nutritional supplements, to retail pharmacy and healthcare channels across Central America and the Caribbean. In addition to its own product portfolio, the company provides contract manufacturing (maquila) services, producing pharmaceutical products for third-party clients using its certified manufacturing infrastructure.

Product overview

Laboratorios COFASA is a pharmaceutical laboratory offering a dual product portfolio organized into two main lines: OTC (Over-the-Counter) for non-prescription products available for direct consumer sale, and OTX (Prescription) for products requiring medical prescription. The OTC line includes analgesics (Neurofenac), stimulants (Sinsueño), digestive aids (Enzyplus), laxatives (Senolax, Mega-Psylium), liver protectors (Proliver), anti-nausea medications (Novomit), sleep inducers (Xiconeural PM, Buensueño), natural sedatives (Xiconatural), nutritional supplements (Pontex, Fosfo B-12, Ferrovitalon), and dewormers (Parazox, Fixtrol). The OTX prescription line includes antibiotics (Clavulax, Cofaxima), antihistamines (Alerless), expectorants (Broxoklem), antifungals (Etimazol), dermatologicals (Etiderm Cream), lipid regulators (Etifibrat, Etilipol), analgesics (Etiprofen), neurological medications (Flugeron, Megaglutan), gastrointestinal treatments (Megalax), and sedatives (Xiconeural 3, Xiconeural S-200, Xiconeural PM, Pontex KIDS, Aerokids). Beyond product commercialization, the company provides contract manufacturing services (maquila) for liquids, semi-solids, and solids, along with quality control services.

Differentiator

Problem solved

Functional benefit

Brands

• COFASA Te Cuida: Corporate social responsibility program providing medical consultations and treatments for employees and their families
• Pontex
• Fosfo B12
• Xiconeural
• Senolax
• Proliver
• Ferrovitalon
• Cofaxima
• Clavulax
• Broxoklem
• Alerless
• Aerokids
• Neurofenac
• Novomit
• Enzyplus
• Megalax
• Mega-Psylium
• Megaglutan
• Pontex Kids
• Etifibrat
• Etilipol
• Parazox
• Buensueño
• Sinsueño
• Etiderm
• Etimazol
• Etiprofen
• Flugeron

Products and services

• Over-the-counter (OTC) pharmaceutical products
• Prescription (OTX) pharmaceutical products
• Nutritional supplements
• Contract manufacturing (maquila) services

Quantifiable outcome

• WHO GMP certification for liquid, solid, and semi-solid manufacturing areas
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Fundación INQUIFARcoreStrategic or Co-development Partner · 26 May 2026Laboratorios COFASA participated in the launch of the Fundación INQUIFAR initiative, a foundation focused on promoting academic projects, social support, and development opportunities for new generations interested in pharmaceutical and scientific sciences. The partnership aims to connect education and health with projects that benefit the social and professional development of students and professionals in El Salvador's pharmaceutical industry.

Scale indicators5 records

Recent moves5 records

Expansion highlights10 records

Direct peers

• Laboratorios Stein: Costa Rica-based pharmaceutical manufacturer with a comparable regional profile: OTC and prescription generics, Central American distribution, and contract manufacturing capabilities. Closest geographic and scale peer to COFASA.
• Procaps: Colombian pharmaceutical company with a dual business model spanning proprietary branded generics and CDMO services across multiple dosage forms — directly comparable to COFASA's OTC/OTX plus maquila structure, albeit at meaningfully larger scale.
• Carnot Laboratorios: Mexican pharmaceutical manufacturer producing generic and branded generics across multiple therapeutic categories with LatAm distribution. Comparable in scale, product mix, and channel strategy to COFASA.
• Maver: Mexican OTC pharmaceutical company with a comparable portfolio breadth (analgesics, gastrointestinal, dermatologicals, supplements) and regional distribution focus. Similar mid-sized LatAm pharma peer with overlapping product categories.

Others

• Glenmark Pharmaceuticals: India-headquartered multinational with growing Latin American generics footprint and CDMO capabilities. Relevant as both a competitive incumbent in regional markets and a potential partner for technology transfer or supply agreements.

Broad incumbents

• Laboratorios Sanfer: Major Mexican pharmaceutical manufacturer with a broad OTC and prescription portfolio and established Central American presence. Operates at significantly larger scale than COFASA but competes in similar therapeutic categories and channels.
• Eurofarma: Brazil's largest privately-held pharmaceutical company with regional LatAm operations including Central America, offering both proprietary generics and CDMO services. Provides a relevant scale benchmark for COFASA's maquila-plus-branded model.
• Genomma Lab Internacional: Mexico-headquartered OTC pharmaceutical powerhouse with extensive Latin American distribution across similar therapeutic categories (analgesics, sleep aids, gastrointestinal, dermatologicals). A broad incumbent competing for the same pharmacy-shelf consumer in overlapping Central American markets.
• Laboratorios Richmond: Argentina-based pharmaceutical manufacturer with branded generics and OTC portfolio distributed across Latin America. Relevant incumbent comparable to COFASA on product breadth and therapeutic coverage, though serving different geography.
• Teva Pharmaceutical Industries: Global generic pharmaceutical leader with established Central American and Caribbean operations. Competes with COFASA on key molecules (Cefixime, Amoxicillin+Clavulanate, Flunarizine) and represents the multinational pressure on regional generic pricing.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/fosfob12
• Instagraminstagram.com/p/DAjlb6Yy4hT
• LinkedInlinkedin.com/company/laboratorios-cofasa

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratorios COFASA